Sarah Hartz
researcherFemale0.0Global Dominance: 0.00%
Dr. Sarah Hartz is a professor of psychiatry at the Washington University School of Medicine in St. Louis, known for her research on Alzheimer's disease and its treatments. She recently gained attention for leading a study that estimates how long patients with mild cognitive decline might maintain their independence when treated with new Alzheimer’s drugs, specifically lecanemab and donanemab.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Senior author Sarah Hartz, MD, PhD, a professor of psychiatry at WashU Medicine, explained the significance of the study's findings.
Two Alzheimer’s drugs help patients live independently at home for longer periodsFox News·
United States· 2025-02-20
United States· 2025-02-20
Dr. Sarah Hartz is the lead author of a new study estimating how long people might continue to live independently after beginning treatment for Alzheimer’s.
Pros and cons of new Alzheimer’s drugs: How long you might live without helpCNN·United States· 2025-02-13
United States· 2025-02-13
